Severe Influenza Patients Who Received Ventilator Management During the 2024 to 2025 Major Influenza-Endemic Season in a Tertiary Hospital in Japan
Open Access
- 1 May 2025
- journal article
- case report
- Published by Taylor & Francis in International Medical Case Reports Journal
- Vol. ume 18, 621-627
Abstract
Three cases of severe influenza that required ventilator management in the 2024– 2025 season, which was a major influenza season in Japan, are presented. Case 1: A 54-year-old man with obesity developed lobar pneumonia as a result of severe community-acquired pneumonia (CAP) secondary to methicillin-susceptible Staphylococcus aureus (MSSA), as confirmed on sputum culture. The nasal swab was positive for influenza A antigen. Intravenous peramivir and piperacillin/tazobactam were administered for 2 days followed by lascufloxacin and linezolid for 2 weeks. Veno-venous extracorporeal membrane oxygenation (VV-ECMO) was also performed. Case 2: A 63-year-old man with multiple myeloma and chronic kidney disease developed severe pneumonia as a result of CAP. Although influenza A antigen was detected, no bacteria were isolated from his specimens. He showed severe hypoxia and massive ground-glass opacities (GGOs) in both lung fields, but he recovered after administration of peramivir and levofloxacin with prednisolone for 2 days and 2 weeks, respectively, with non-invasive positive pressure support. Case 3: A 43-year-old man without any related medical history developed severe heart failure with mild bronchopneumonia and was admitted to our hospital. Acute heart failure caused by myocarditis and CAP due to influenza A were suspected and treated effectively with peramivir and a percutaneous ventricular assist device (IMPELLA), which involved an auxiliary circulating pump with veno-arterial ECMO (VA-ECMO) for 1 day and 2 weeks, respectively. In three middle-aged patients, influenza virus may have accelerated pneumonia/heart failure. All three patients had not received influenza vaccines and were not elderly. Although the emphasis on most vaccines has decreased after the COVID-19 pandemic appears to have subsided, we should stress the importance of influenza vaccines and improvement of critical care protocols, because severe influenza can be a concern for young and middle-aged adults during the influenza season after the post COVID-19 pandemic period.Keywords
This publication has 23 references indexed in Scilit:
- Resurgence of human metapneumovirus infection and influenza after three seasons of inactivity in the post‐COVID‐19 era in Hokkaido, Japan, 2022–2023Journal of Medical Virology, 2023
- Diagnosis and Treatment of Acute MyocarditisJAMA, 2023
- Understanding the rebound of influenza in the post COVID-19 pandemic period holds important clues for epidemiology and controlInternational Journal of Infectious Diseases, 2022
- Clinical manifestations of hospitalized influenza patients without risk factors: A prospective multicenter cohort study in Japan via internet surveillanceJournal of Infection and Chemotherapy, 2022
- Psychological factors underpinning vaccine willingness in Israel, Japan and HungaryScientific Reports, 2022
- Clinical manifestations of adult patients requiring influenza-associated hospitalization: A prospective multicenter cohort study in Japan via internet surveillanceJournal of Infection and Chemotherapy, 2021
- Single-Center Experience With Venovenous ECMO for Influenza-Related ARDSJournal of Cardiothoracic and Vascular Anesthesia, 2018
- Timing of ECMO Initiation Impacts Survival in Influenza-Associated ARDSThe Thoracic and Cardiovascular Surgeon, 2018
- Seasonal influenza vaccine in immunocompromised personsHuman Vaccines & Immunotherapeutics, 2018
- Impact of Respiratory Virus Infections on Persons With Chronic Underlying ConditionsJAMA, 2000